Financhill
Buy
69

PMCB Quote, Financials, Valuation and Earnings

Last price:
$1.02
Seasonality move :
35.79%
Day range:
$1.06 - $1.20
52-week range:
$0.63 - $1.90
Dividend yield:
0%
P/E ratio:
0.40x
P/S ratio:
239.61x
P/B ratio:
0.17x
Volume:
1.8M
Avg. volume:
6.7M
1-year change:
-33.53%
Market cap:
$7.5M
Revenue:
--
EPS (TTM):
-$0.46

Earnings Data

Next earnings date for PMCB
--
Most recent earnings per share
-$1.23
Missed by $1.23
(Jul 31/2025)
Consensus Estimate
--
(Jul 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PMCB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/31/2025 Q3 -- -- -$1.23 -- --
04/30/2025 Q2 -- -- $1.60 -- --
03/17/2025 Q1 -- -- -$0.44 -- --
12/13/2024 Q4 -- -- -$0.39 -- --
09/17/2024 Q3 -- -- $1.90 -- --
04/30/2024 Q2 -- -- -$0.32 -- --
03/18/2024 Q1 -- -- -$0.65 -- --
12/15/2023 Q4 -- -- -$0.26 -- --
07/31/2023 Q3 -- -- -$0.54 -- --
04/30/2023 Q2 -- -- -$0.01 -- --
03/16/2023 Q1 -- -- -$0.04 -- --
12/14/2022 Q4 -- -- -$0.09 -- --
09/14/2022 Q3 -- -- -$0.07 -$0.07 -$0.00
07/11/2022 Q2 -- -- -$0.89 -$0.04 -$0.85
03/16/2022 Q1 -- -- -$0.04 -$0.05 $0.01
12/14/2021 Q4 -- -- -$0.06 -$0.07 $0.01
09/14/2021 Q3 -- -- -$0.64 -- --
04/30/2021 Q2 -- -- -$0.62 -- --
01/31/2021 Q1 -- -- -$0.48 -- --
10/31/2020 Q4 -- -- -$0.62 -- --
07/31/2020 Q3 -- -- -$0.80 -- --
04/30/2020 Q2 -- -- -$0.69 -- --
01/31/2020 Q1 -- -- -$0.96 -- --
10/31/2019 Q4 -- -- -$1.22 -- --
07/31/2019 Q3 -- -- -$1.41 -- --
04/30/2019 Q2 -- -- -$1.50 -- --
01/31/2019 Q1 -- -- -$0.90 -- --
10/31/2018 Q4 -- -- -$1.44 -- --
07/31/2018 Q3 -- -- -$1.74 -- --
04/30/2018 Q2 -- -- -$1.92 -- --
01/31/2018 Q1 -- -- -$3.12 -- --
10/31/2017 Q4 -- -- -$2.79 -- --
07/31/2017 Q3 -- -- -$2.73 -- --
04/30/2017 Q2 -- -- -$1.92 -- --
01/31/2017 Q1 -- -- -$2.24 -- --
10/31/2016 Q4 -- -- -$1.73 -- --
07/31/2016 Q3 -- -- -$1.97 -- --
04/30/2016 Q2 -- -- -$2.16 -- --
01/31/2016 Q1 -- -- -$3.56 -- --

PharmaCyte Biotech, Inc. Earnings Questions

  • How Much did PharmaCyte Biotech, Inc. Generate in Revenue Last Quarter?

    PharmaCyte Biotech, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did PharmaCyte Biotech, Inc. Beat Earnings Last Quarter?

    PharmaCyte Biotech, Inc. announced earnings per share of -$1.23 which represents a miss of analyst forecast a -- per share.

  • Is PharmaCyte Biotech, Inc. Profitable?

    PharmaCyte Biotech, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for PharmaCyte Biotech, Inc. EPS Next Year?

    PharmaCyte Biotech, Inc.'s earnings are forecast to grow from $3.19 per share to -- per share next year representing an increase of --.

  • When is PharmaCyte Biotech, Inc.'s Earnings Date?

    Currently, PharmaCyte Biotech, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
50
PLAB alert for Dec 10

Photronics, Inc. [PLAB] is up 45.35% over the past day.

Buy
60
OLMA alert for Dec 10

Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.

Buy
84
TSAT alert for Dec 10

Telesat Corp. [TSAT] is up 3.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock